Uqora Maximum Strength Urinary Pain Relief

Product NDC: 73712-113
11-digit product format: 737120113
Labeler code: 73712
Product ID: 73712-113_9d499d81-f689-490d-9f92-ea685c3622af
Type: HUMAN OTC DRUG
Nonproprietary name: PHENAZOPYRIDINE HYDROCHLORIDE
Dosage form: TABLET
Route: ORAL
Labeler: Uqora Inc
Marketing category: UNAPPROVED DRUG OTHER
Marketing start: 2020-04-29
Marketing end: 0000-00-00
Substance: PHENAZOPYRIDINE HYDROCHLORIDE
Active strength: 100 mg/1
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	73712-113		D	Discontinued by firm		2026-10-05
excluded package	package	73712-113	73712-113-24	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 2 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Archive	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product	73712-113		D	Discontinued by firm		excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	73712-113	73712-113-24	D	Discontinued by firm		excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
260b0da6-d3d7-262f-a60f-d4b36d5f1b4d	Product name	6	20251210
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73712-113	UQORA MAXIMUM STRENGTH URINARY PAIN RELIEF (PHENAZOPYRIDINE HYDROCHLORIDE) TABLET [UQORA INC]	4	Legacy NDC	20241220_5c46eee9-4594-43f5-9e93-088905d9fe11.zip
73712-113	ALL-IN-ONE UTI EMERGENCY KIT (METHENAMINE, SODIUM SALICYLATE, AND PHENAZOPYRIDINE HYDROCHLORIDE) KIT [UQORA INC]	2	Legacy NDC	20241219_ebde96d2-e1f2-26b1-e053-2a95a90a2fb1.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
0EWG668W17	PHENAZOPYRIDINE HYDROCHLORIDE	136-40-3	PHENAZOPYRIDINE HYDROCHLORIDE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
73712-113-24	73712011324	2 BLISTER PACK in 1 CARTON (73712-113-24) > 12 TABLET in 1 BLISTER PACK	2 blister pack	2020-04-29	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DRUG FACTS	Uqora Inc \| Reese Pharmaceutical Co	2024-12-18	HUMAN OTC DRUG LABEL	4
Uqora All-In-One UTI Emergency Kit	UQORA INC \| Pharbest	2024-12-17	HUMAN OTC DRUG LABEL	2